Annual Accounts Receivable
N/A
December 1, 2023
Summary
- CAMP annual accounts receivable is not available.
Performance
CAMP Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$1.00 M
NaN%
September 1, 2024
Summary
- As of February 8, 2025, CAMP quarterly accounts receivable is $1.00 million
- Over the past year, CAMP quarterly accounts receivable has dropped by -$70.39 million (-98.60%).
- CAMP quarterly accounts receivable is now -98.86% below its all-time high of $87.73 million, reached on November 30, 2022.
Performance
CAMP Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CAMP Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -98.6% |
| 3 y3 years | - | -98.7% |
| 5 y5 years | - | -98.4% |
CAMP Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.9% | at low | ||
| 5 y | 5-year | -98.9% | at low | ||
| alltime | all time | -98.9% | at low |
CAMP4 Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.00 M(-98.6%) |
| Nov 2023 | - | $70.91 M(-0.7%) |
| Aug 2023 | - | $71.39 M(-16.1%) |
| May 2023 | - | $85.03 M(+2.5%) |
| Feb 2023 | - | $82.95 M(-5.5%) |
| Feb 2023 | $82.95 M(+34.8%) | - |
| Nov 2022 | - | $87.73 M(+17.3%) |
| Aug 2022 | - | $74.80 M(+13.3%) |
| May 2022 | - | $66.05 M(+7.3%) |
| Feb 2022 | $61.54 M(-2.8%) | $61.54 M(+5.0%) |
| Nov 2021 | - | $58.59 M(-5.9%) |
| Aug 2021 | - | $62.29 M(-3.4%) |
| May 2021 | - | $64.49 M(+1.8%) |
| Feb 2021 | $63.33 M(-2.0%) | $63.33 M(-6.7%) |
| Nov 2020 | - | $67.85 M(-0.8%) |
| Aug 2020 | - | $68.39 M(+2.1%) |
| May 2020 | - | $67.00 M(+3.6%) |
| Feb 2020 | $64.64 M(-17.2%) | $64.64 M(-22.6%) |
| Nov 2019 | - | $83.46 M(+10.4%) |
| Aug 2019 | - | $75.60 M(+2.7%) |
| May 2019 | - | $73.64 M(-5.7%) |
| Feb 2019 | $78.08 M(+9.1%) | $78.08 M(+7.8%) |
| Nov 2018 | - | $72.43 M(+2.0%) |
| Aug 2018 | - | $70.98 M(+1.7%) |
| May 2018 | - | $69.81 M(-2.5%) |
| Feb 2018 | $71.58 M(+6.2%) | $71.58 M(+2.0%) |
| Nov 2017 | - | $70.19 M(+8.8%) |
| Aug 2017 | - | $64.49 M(-1.5%) |
| May 2017 | - | $65.50 M(-2.8%) |
| Feb 2017 | $67.40 M(+36.4%) | $67.40 M(+0.6%) |
| Nov 2016 | - | $66.97 M(-2.6%) |
| Aug 2016 | - | $68.77 M(-0.9%) |
| May 2016 | - | $69.39 M(+40.4%) |
| Feb 2016 | $49.43 M(+3.2%) | $49.43 M(+10.0%) |
| Nov 2015 | - | $44.95 M(-1.9%) |
| Aug 2015 | - | $45.80 M(+1.6%) |
| May 2015 | - | $45.07 M(-5.9%) |
| Feb 2015 | $47.92 M(+29.8%) | $47.92 M(+5.6%) |
| Nov 2014 | - | $45.37 M(+18.5%) |
| Aug 2014 | - | $38.28 M(+10.0%) |
| May 2014 | - | $34.80 M(-5.7%) |
| Feb 2014 | $36.90 M(+93.1%) | $36.90 M(+19.4%) |
| Nov 2013 | - | $30.90 M(+12.1%) |
| Aug 2013 | - | $27.56 M(+8.1%) |
| May 2013 | - | $25.50 M(+33.4%) |
| Feb 2013 | $19.11 M | $19.11 M(-8.4%) |
| Nov 2012 | - | $20.87 M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2012 | - | $19.62 M(+2.4%) |
| May 2012 | - | $19.16 M(+33.2%) |
| Feb 2012 | $14.38 M(-14.5%) | $14.38 M(-8.7%) |
| Nov 2011 | - | $15.76 M(+8.5%) |
| Aug 2011 | - | $14.52 M(-8.9%) |
| May 2011 | - | $15.94 M(-5.2%) |
| Feb 2011 | $16.81 M(+1.8%) | $16.81 M(+23.2%) |
| Aug 2010 | - | $13.65 M(+1.7%) |
| May 2010 | - | $13.42 M(-18.7%) |
| Feb 2010 | $16.52 M(+20.7%) | $16.52 M(+14.3%) |
| Nov 2009 | - | $14.46 M(+18.7%) |
| Aug 2009 | - | $12.18 M(-12.5%) |
| May 2009 | - | $13.92 M(+1.7%) |
| Feb 2009 | $13.68 M(-31.7%) | $13.68 M(-10.8%) |
| Nov 2008 | - | $15.34 M(-7.7%) |
| Aug 2008 | - | $16.61 M(+3.8%) |
| May 2008 | - | $16.00 M(-20.2%) |
| Feb 2008 | $20.04 M(-47.9%) | $20.04 M(-7.7%) |
| Nov 2007 | - | $21.71 M(-12.6%) |
| Aug 2007 | - | $24.84 M(-3.2%) |
| May 2007 | - | $25.65 M(-33.3%) |
| Feb 2007 | $38.44 M(+34.3%) | $38.44 M(+27.0%) |
| Nov 2006 | - | $30.27 M(-22.0%) |
| Aug 2006 | - | $38.82 M(+36.2%) |
| May 2006 | - | $28.50 M(-0.5%) |
| Feb 2006 | $28.63 M(+5.9%) | $28.63 M(-20.8%) |
| Nov 2005 | - | $36.16 M(+41.4%) |
| Aug 2005 | - | $25.57 M(+6.1%) |
| May 2005 | - | $24.10 M(-10.8%) |
| Feb 2005 | $27.03 M(+45.5%) | $27.03 M(-5.4%) |
| Nov 2004 | - | $28.57 M(+11.5%) |
| Aug 2004 | - | $25.62 M(+22.4%) |
| May 2004 | - | $20.93 M(+12.7%) |
| Feb 2004 | $18.58 M(+15.7%) | $18.58 M(+6.8%) |
| Nov 2003 | - | $17.40 M(+35.0%) |
| Aug 2003 | - | $12.88 M(+92.9%) |
| May 2003 | - | $6.68 M(-58.4%) |
| Feb 2003 | $16.05 M(+95.3%) | $16.05 M(+65.3%) |
| Nov 2002 | - | $9.71 M(-13.5%) |
| Aug 2002 | - | $11.24 M(+9.6%) |
| May 2002 | - | $10.26 M(+24.8%) |
| Feb 2002 | $8.22 M(-27.8%) | $8.22 M(-47.2%) |
| Nov 2001 | - | $15.58 M(+33.0%) |
| Aug 2001 | - | $11.71 M(-14.4%) |
| May 2001 | - | $13.69 M(+20.3%) |
| Feb 2001 | $11.38 M(-29.0%) | $11.38 M(-29.0%) |
| Feb 2000 | $16.04 M(+220.8%) | $16.04 M(+220.8%) |
| Feb 1999 | $5.00 M | $5.00 M |
FAQ
- What is the all time high annual accounts receivable for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics quarterly accounts receivable year-on-year change?
What is the all time high annual accounts receivable for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high annual accounts receivable is $82.95 M
What is CAMP4 Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CAMP is $1.00 M
What is the all time high quarterly accounts receivable for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high quarterly accounts receivable is $87.73 M
What is CAMP4 Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CAMP quarterly accounts receivable has changed by -$70.39 M (-98.60%)